Pharyngeal DiseasesPharyngeal MusclesPharynxPharyngeal NeoplasmsSurvival RateDisease-Free SurvivalSurvival AnalysisTreatment OutcomeBranchial RegionPrognosisCell SurvivalAntineoplastic Combined Chemotherapy ProtocolsKaplan-Meier EstimateNeoplasm StagingRetrospective StudiesCombined Modality TherapySurvivalDeglutitionNeoplasm Recurrence, LocalFollow-Up StudiesProportional Hazards ModelsTime FactorsTumor Markers, BiologicalChemotherapy, AdjuvantAntineoplastic AgentsBreast NeoplasmsFluorouracilGraft SurvivalLung NeoplasmsMultivariate AnalysisNeoplasm MetastasisCisplatinHyoid BoneAdenocarcinomaVincristineCyclophosphamideDoxorubicinDisease ProgressionImmunohistochemistryLymphatic MetastasisDrug Administration ScheduleCarcinoma, Squamous CellPalate, SoftRemission InductionRadiotherapy, AdjuvantDeoxycytidineGaggingProspective StudiesCarcinoma, Non-Small-Cell LungLiver NeoplasmsRecurrenceColorectal NeoplasmsPrednisoneBrain NeoplasmsHypopharynxTongueOropharynxNeoadjuvant TherapySalvage TherapyEsophageal Sphincter, UpperDeglutition DisordersRisk FactorsPredictive Value of TestsOrganoplatinum CompoundsOvarian NeoplasmsMouth NeoplasmsAntibodies, Monoclonal, HumanizedJawCohort StudiesEtoposideChemoradiotherapyLarynxNeural CrestLeucovorinTaxoidsHead and Neck NeoplasmsCarcinomaTransplantation, AutologousDacarbazineAntimetabolites, Antineoplastic